investorscraft@gmail.com

Intrinsic ValueNeurones S.A. (NRO.PA)

Previous Close40.30
Intrinsic Value
Upside potential
Previous Close
40.30

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Neurones S.A. is a France-based IT services company specializing in infrastructure management, application development, and digital transformation consulting. The company operates across multiple verticals, including banking, healthcare, energy, and public sectors, offering tailored solutions such as cloud services, cybersecurity, SAP integration, and AI-driven analytics. Its diversified service portfolio positions it as a comprehensive IT partner, addressing both operational efficiency and strategic digital transformation needs for clients. Neurones differentiates itself through a hybrid approach, combining managed services with innovation-driven consulting, particularly in emerging technologies like blockchain, IoT, and machine learning. The firm’s focus on sectors with high regulatory and technological complexity, such as finance and healthcare, reinforces its reputation for reliability and technical expertise. While it faces competition from global IT giants and niche players, its deep regional presence in France and selective international expansion provide a stable revenue base. The company’s emphasis on agile methodologies and DevOps further aligns it with modern enterprise demands for scalable, iterative IT solutions.

Revenue Profitability And Efficiency

Neurones reported revenue of €810.4 million for the period, with net income of €52.5 million, reflecting a net margin of approximately 6.5%. The absence of disclosed operating cash flow and capital expenditures limits deeper efficiency analysis, but the company’s profitability suggests disciplined cost management. Its diluted EPS of €2.16 indicates steady earnings generation relative to its share count.

Earnings Power And Capital Efficiency

The company’s earnings power is underscored by its consistent profitability, with a net income that supports its dividend policy. Capital efficiency metrics are incomplete due to missing cash flow data, but the modest total debt of €42 million against €326.5 million in cash reserves suggests a conservative leverage profile and strong liquidity positioning.

Balance Sheet And Financial Health

Neurones maintains a robust balance sheet, with cash and equivalents of €326.5 million significantly outweighing its total debt of €42 million. This low-leverage structure enhances financial flexibility, reducing vulnerability to macroeconomic volatility. The company’s equity base, supported by retained earnings, further solidifies its financial stability.

Growth Trends And Dividend Policy

The company’s growth trajectory appears stable, though specific YoY comparisons are unavailable. Its dividend payout of €1.20 per share aligns with a shareholder-friendly policy, offering a yield that complements its moderate earnings growth. The lack of detailed historical data limits trend analysis, but the current metrics suggest a balanced approach to reinvestment and returns.

Valuation And Market Expectations

With a market capitalization of €1.11 billion, Neurones trades at a P/E multiple derived from its €2.16 EPS, reflecting investor confidence in its niche IT services positioning. The beta of 0.591 indicates lower volatility relative to the broader market, appealing to risk-averse investors. Market expectations likely hinge on its ability to sustain margins amid digital transformation demand.

Strategic Advantages And Outlook

Neurones’ strategic advantages lie in its sector-specific expertise and hybrid service model, blending infrastructure management with high-value consulting. The outlook remains positive, driven by secular demand for digital transformation, though competition and pricing pressures in IT services could pose challenges. Its strong balance sheet provides a cushion for strategic investments or acquisitions to bolster growth.

Sources

Company description, financial data from public filings (likely Euronext disclosures), and market data from financial platforms.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount